NCT03922126 is a NA clinical trial of Peer counseling in HIV Infections, sponsored by University of Washington.

Who is sponsoring NCT03922126?

NCT03922126 is sponsored by University of Washington.

What drugs are being tested in NCT03922126?

Interventions in NCT03922126: Peer counseling, HIV/STI self-testing kits.

What condition does NCT03922126 study?

NCT03922126 studies HIV Infections, Sexually Transmitted Diseases.

Is NCT03922126 still recruiting?

NCT03922126 is currently completed. Last updated 17 May 2022.

Last reviewed 2022-05-17 · How we verify

NCT03922126

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peer Intervention Latino Immigrant MSM

Completed NA Last updated 17 May 2022

What this trial tests

NA trial testing Peer counseling in HIV Infections in 50 participants. Completed in 28 February 2022.

Timeline

1 May 2019

Primary endpoint
1 February 2022

28 February 2022

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	50
Start date	1 May 2019
Primary completion	1 February 2022
Estimated completion	28 February 2022
Sites	1 location across United States

Drugs / interventions tested

Peer counseling
HIV/STI self-testing kits

Conditions studied

HIV Infections — all drugs for HIV Infections →
Sexually Transmitted Diseases — all drugs for Sexually Transmitted Diseases →

Sponsor

University of Washington

Who can join

18 and older, male only, with HIV Infections or Sexually Transmitted Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates a peer intervention with HIV/STI self-testing kits to increase HIV/STI testing and PrEP uptake among Latino immigrant men who have sex with men. Half of participants will receive the "Listos" intervention (peer counseling, PrEP information, and HIV/STI testing kits) and half will receive the active control intervention (peer only group with no HIV/STI testing kits).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Peer-Based Intervention to Increase HIV and Sexually Transmitted Infection Testing Among Latinx Immigrant Sexual Minority Men in the US Pacific Northwest: Pilot Randomized Controlled Trial Conducted During the COVID-19 Pandemic.
Lee JJ, Robles G, Leyva Vera CA, Orellana ER, et al · · 2023 · cited 4× · PMID 37436792 · DOI 10.2196/45871

Verify or expand the search:

Other trials of Peer counseling

Trials testing the same drug.

NCT06921382 — Breastfeeding Intervention to Prevent Obesity Among Children · NA · recruiting
NCT00186602 — Does a Peer Navigator Improve Quality of Life at Diagnosis for Women With Breast Cancer? · completed

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03922126 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 17 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing